Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-01-25
2011-01-25
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S134100, C530S395000
Reexamination Certificate
active
07875585
ABSTRACT:
The invention feature methods and compositions for treating hematopoietic disorders, inflammatory conditions, and cancer and providing stem cell therapy in a mammal.
REFERENCES:
patent: 5652343 (1997-07-01), Lasky et al.
patent: 5849898 (1998-12-01), Seed et al.
patent: 5942417 (1999-08-01), Ni et al.
patent: 6124267 (2000-09-01), McEver et al.
patent: 2003/0040607 (2003-02-01), Sackstein
patent: WO 92/01049 (1992-01-01), None
patent: WO 96/11012 (1996-04-01), None
Skolnick et al. Trends in Biotechnology 18:34-39 (2000).
Ngo et al. in The Protein Folding Problem and Tertiary Structure Prediction 1994, Merz et al. (ED) Birkhauser Boston MA pp. 433, 492-495.
Dimitroff et al. J. Biol Chem 276: 46723-47631 (2001).
Stamenkovic et al. EMBO Journal 10: 343-348 (1991).
Sackstein et al. Blood 89: 2773-2781 (1997).
Sackstein (J. Invest. Dermatol. 122: 1061-1069, 2004).
Candal et al., “BMEC-1: A Human Bone Marrow Microvascular endothelial Cell Line with Primary Cell Characteristics,”Microvasc. Research, 52:221-234 (1996).
DeLuca et al., “A Novel Cobra Venom Metalloproteinase, Mocarhagin, Cleaves a 10-Amino Acid Peptide from the Mature N Terminus of P-selectin Glycoprotein Ligand Receptor, PSGL-1, and Abolishes P-selectin Binding,”J. Biological Chem. 270(45):26734-26737 (1995).
Dimitroff et al., “A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells,”PNAS97(25):13841-13846 (2000).
Dougherty et al., “Molecular Cloning of CD44R1 and CD44R2, Two Novel Isoforms of the Human CD44 Lymphocyte ‘Homing’ Receptor Expressed by Hemopoietic Cells,”J. Exp. Med. 174:1-5 (1991).
Finger et al., “Adhesion through L-selectin requires a threshold hydrodynamic shear,”Nature379:266-269 (1996).
Fuhlbrigge et al., “Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells,”Nature389:978-981 (1997).
Goelz et al., “Differential Expression of an E-selectin Ligand (Slex) by Two Chinese Hamster Ovary Cell Lines Transfected with the Same α(1,3)-Fucosyltransferase Gene (ELFT),”J. Biological Chem., 269(2):1033-1040 (1994).
Guyer et al., “P-Selectin Glycoprotein Ligand-1 (PSGL-1) Is a Ligand for L-Selectin in Neutrophil Aggregation,”Blood88(7):2415-2421 (1996).
Hale, L. and Haynes, B., “Bromelain Treatment of Human T Cells Removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 Surface Molecules and Markedly Enhances CD2-Mediated T Cell Activation,”J. Immunol. 149(12):3809-3816 (1992).
Jalkanen et al., “A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man,”Eur. J. Immunol. 16:1195-1202 (1986).
Jalkanen et al., “Biochemical Properties of Glycoproteins Involved in Lymphocyte Recognition of High Endothelial Venules in Man,”J. Immunol. 141(5):1615-1623 (1988).
Kugleman et al., “The Core Protein of Epican, a Heparan Sulfate Proteoglycan on Keratinocytes, Is an Alternative Form of CD44,”The Society for Investigative Dermatology, Inc., pp. 887-891 (1992).
Lawrence et al., “Effect of Flow on Polymorphonuclear Leukocyte/Endothelial Cell Adhesion,”Blood70(5):1284-1290 (1987).
Lawrence et al., “Threshold Levels of Fluid Shear Promote Leukocyte Adhesion through Selectins (CD62L,P,E),”J. Cell Biol. 136(3):717-727 (1999).
Oxley et al., “Detection of an L-Selectin Ligand on a Hematopoietic Progenitor Cell Line,”Blood84(10):3299-3306 (1994).
Ramos et al., “Functional Characterization of L-Selectin Ligands on Human Neutrophils and Leukemia Cell Lines: Evidence for Mucinlike Ligand Activity Distinct From P-Selectin Glycoprotein Ligand-1,”Blood91(3):1067-1075 (1998).
Sackstein et al., “Hematopoietic Cell L-Selectin Ligand Exhibits Sulfate-Independent Binding Activity,”Blood89(8):2773-2781 (1997).
Sackstein, R., and Dimitroff, C., “A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity,”Blood96(8):2765-2774 (2000).
Sasaki et al., “Expression Cloning of a Novel Galβ(1-3/1-4)GlcNAc α2,3-Sialyltransferase Using Lectin Resistance Selection,”J. Biol. Chem., 268(30):22782-22787 (1993).
Snapp et al., “A Novel P-Selectin Glycoprotein Ligand-1 Monoclonal Antibody Recognizes an Epitope Within the Tyrosine Sulfate Motif of Human PSGL-1 and Blocks Recognition of Both P-and L-Selectin,”Blood91(1):154-164 (1998).
Spertini et al., “P-Selectin Glycoprotein Ligand 1 Is a Ligand for L-Selectin on Neutrophils, Monocytes, and CD34+ Hematopoietic Progenitor Cells,”J. Cell Biol. 135(2):523-531 (1996).
Stamenkovic et al., “The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells,”EMBO Journal, 10(2):343-348 (1991).
Tu et al., “L-Selectin Binds to P-Selectin Glycoprotein Ligand-1 on Leukocytes: Interactions Between the Lectin, Epidermal Growth Factor, and Consensus Repeat Domains of the Selectins Determine Ligand Binding Specificity,”J. Immunol. 157(9):3995-4004 (1996).
Vachino et al., “P-selectin Glycoprotein Ligand-1 Is the Major Counter-receptor for P-selectin on Stimulated T Cells and Is Widely Distributed in Non-functional Form on Many Lymphocytic Cells,”J. Biol. Chem. 270(37):21966-21974 (1995).
Zollner, O., and Vestweber, D., “The E-selectin Ligand-1 Is Selectively Activated in Chinese Hamster Ovary Cells by the α(1,3)-Fucosyltransferases IV and VII,”J. Biol. Chem. 271(51):33002-33008(1996).
Sharon et al., Carbohydrates in Cell Recognition, Scientific American, Jan. 1993, pp. 82-89.
Oxley et al., L-Selectin-CD34 Interactions Mediate Functional Binding of Lymphocytes to Hematopoietic Progenitor Cells, Clinical Research, 1994, vol. 42, No. 2, p. 235A.
Shimizu et al., Mucins in the Mainstream, Nature, Dec. 16, 1993, vol. 366, pp. 630-631.
Arbones et al., Lymphocyte Homing and Leukocyte Rolling and Migration are Impared in L-Selectin-Deficient Mice, Immunity, 1994, vol. 1, pp. 247-260.
Rosen, Cell Surface Lectins in the Immune System, Seminars in Immunology, 1993, vol. 5, pp. 237-247.
Bertozzi, Cracking the Carbohydrate Code for Selectin Recognition, Chemistry & Biology, Nov. 1995, vol. 2, pp. 703-708.
Sackstein et al., Evidence of Post-transcriptional Regulation of L-Selectin Gene Expression in Rat Lymphoid Cells, Immunology, 1995, vol. 85, pp. 198-204.
Jung et al., Rapid Modulation of Homing Receptors (gp90MEL-14) Induced by Activators of Protein Kinase C, J. of Immunology, Apr. 1990, vol. 144, pp. 3130-3136.
Li et al., Post-translational Modifications of Recombinant P-Selectin Glycoprotein Ligand-1 Required for Binding to P-and E-Selectin, J. of Biological Chemistry, Feb. 1996, vol. 271, pp. 3255-3264.
Arbones ML, et al., “Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice,”Immunity., 1:247-260 (1994).
Aruffo, Alejandro, et al., “CD62/P-Selectin Recognition of Myeloid and Tumor Cell Sulfatides,”Cell, vol. 67, 35-44 (1991).
Asa D, et al., “The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P- and E-selectins,”J. Biol. Chem.;270:11662-11670 (1995).
Baeuerle, Patrick A. et al., “Chlorate—A Potent Inhibitor of Protein Sulfation in Intact Cells,”Biochemical and Biophysical Research Communications, vol. 141, No. 2, 870-877 (1986).
Baumhueter, S. et al., “Binding of L-Selectin to the Vascular Sialomucin CD34,”Science, vol. 262, No. 5132, 436-438 (1993).
Berg, EL, et al., “L-selectin-mediated lymphocyte rolling on MAdCAM-1,”Nature, vol. 366 (1993).
Bertozzi, “Cracking the carbohydrate code for selectin recognition,”Chemistry&Biology, 2:703-708 (1995).
Bevilacqua, Michael P. et al., “Selectins,”J. Clin. Invest., Perspecti
Gambel Phillip
Kozakiewicz Cynthia
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Hematopoietic cell E-selectin / L-selectin ligand... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hematopoietic cell E-selectin / L-selectin ligand..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hematopoietic cell E-selectin / L-selectin ligand... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2679102